UPHL — Uphealth Cashflow Statement
0.000.00%
- $0.00m
- $148.21m
- $130.00m
- 33
- 92
- 28
- 50
Annual cashflow statement for Uphealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -2.19 | -341 | -223 | -56.4 |
Depreciation | ||||
Deferred Taxes | ||||
Non-Cash Items | 0.08 | 272 | 185 | 5.75 |
Unusual Items | ||||
Equity in Net Earnings/Losses | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 1.27 | -7.87 | 2.92 | 23.3 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Prepaid Expenses | ||||
Change in Accrued Expenses | ||||
Change in Payable / Accrued Expenses | ||||
Change in Taxes Payable | ||||
Change in Other Liabilities | ||||
Cash from Operating Activities | -1.14 | -62.8 | -22.4 | -17.7 |
Capital Expenditures | — | -3.72 | -6.84 | -3.97 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | 3.51 | 4.47 | -8.76 | 19.2 |
Acquisition of Business | ||||
Sale of Business | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | 3.51 | 0.743 | -15.6 | 15.3 |
Financing Cash Flow Items | — | 76.3 | -20.2 | -1.16 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | — | 136 | -22.8 | -10.6 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 2.37 | 74.4 | -61.2 | -13 |